Efficacy of Tildrakizumab in PsA: DAPSA Remission and Low Disease Activity in PASDAS Through Week 52

Chohan, S; Kavanaugh, A; Strand, V; Chou, R; Mendelsohn, A; Rozzo, S; Mease, P

ARTHRITIS & RHEUMATOLOGY, 2020; 72 ():